Sherlock BioSciences, an engineering biology company co-founded by NetBet PokerOmar Abudayyeh, Ph.D. ’18 (bioengineering) recently launched with initial financing of $35 million.
The startup seeks to use engineering biology tools, including synthetic biology and CRISPR, to create a new generation NetBet Casinoof molecular diagnostics that can rapidly deliver accurate and inexpensive results. Abudayyeh is currently a Fellow at the McGovern Institute for Brain Renetbet casino appSearch at MIT.
Sherlock’s technology is based on renetbet casino appSearch conducted at Harvard’s Wyss Institute for Biologically Inspired Engineering and the Eli and Edythe L. Broad Institute of MIT and Harvard.
Read more in this press release.
Share Your News
Have you made the headlines? Do you have news to share with your classmates and NetBet Pokercolleagues? Send your news items and photos to azewe@seas.harvard.edu.